美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

亞盛醫藥

40.50

+1.924.97%

盤後：40.500.00000.00%16:10 EDT

成交量：1.17萬

成交額：47.36萬

市值：37.65億

市盈率：-55.06

高：41.14

開：40.98

低：39.91

收：38.58

52周最高：48.45

52周最低：16.50

股本：9,296.34萬

流通股本：7,158.28萬

量比：1.14

換手率：0.02%

股息：- -

股息率：- -

每股收益(TTM):-0.7356

每股收益(LYR):-0.7356

淨資產收益率：-159.65%

總資產收益率：-22.77%

市淨率：40.31

市盈率(LYR):-55.06

資料載入中...

總覽公司新聞公告

亞盛醫藥-B(06855)：利生妥®一線治療中高危MDS患者的全球註冊III期臨牀研究獲美國FDA和歐洲EMA批准

亞盛醫藥-B08月13日獲主力加倉1320.6萬元

亞盛醫藥8月11日成交額為9.30萬美元

亞盛醫藥-B：董事會會議通告

香港交易所

小摩：升亞盛醫藥目標價至93港元評級“增持”

小摩：升亞盛醫藥(06855.HK)目標價至93港元評級“增持”

亞盛醫藥8月7日成交額為13.12萬美元

亞盛醫藥上漲2.38%，報43.0美元/股，總市值39.97億美元

亞盛醫藥8月4日成交額為10.83萬美元

亞盛醫藥8月1日成交額為35.92萬美元

亞盛醫藥7月30日成交額為28.97萬美元

亞盛醫藥上漲2.29%，報40.168美元/股，總市值37.34億美元

國內首款Bcl-2抑制劑利生妥®在京東健康全網首發助力血液腫瘤精準治療

特朗普再喊話：美聯儲必須降息！美股小幅上漲，金價急跌！這隻中概股大漲超20%

美股高開中概股多數上揚阿里巴巴漲超2%

亞盛醫藥完成配售2200萬股淨籌14.925億港元

首款國產Bcl-2抑制劑“首方”快速落地，釋放的4個信號

振東製藥股價異動周內上漲超40%；康方生物明星藥物衝刺非小細胞肺癌第三項適應證 | 掘金創新藥

每日经济新闻

亞盛醫藥-B(06855.HK)完成先舊後新配售2200萬股股份淨籌約14.925億港元

亞盛醫藥7月24日成交額為41.72萬美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AAPG/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"亞盛醫藥","latestPrice":40.4987,"timestamp":1757102400000,"preClose":38.58,"halted":0,"volume":11693,"hourTrading":{"tag":"盘后","latestPrice":40.4987,"preClose":40.4987,"latestTime":"16:10 EDT","volume":79,"amount":3202.85,"timestamp":1757103004016},"delay":0,"floatShares":71582800,"shares":92963368,"eps":-0.735552,"marketStatus":"休市中","change":1.9187,"latestTime":"09-05 16:00:00 EDT","open":40.98,"high":41.135,"low":39.91,"amount":473616.9924,"amplitude":0.031752,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.735552,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1757318400000},"marketStatusCode":7,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":38.58,"preHourTrading":{"tag":"盘前","latestPrice":40.66,"preClose":38.29,"latestTime":"09:21 EDT","volume":770,"amount":31832.85182,"timestamp":1757078476206},"postHourTrading":{"tag":"盘后","latestPrice":40.4987,"preClose":40.4987,"latestTime":"16:10 EDT","volume":79,"amount":3202.85,"timestamp":1757103004016},"volumeRatio":1.136544779456076},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","floatShares":71582800,"roa":"-22.77%","roe":"-159.65%","lyrEps":-0.735552,"volumeRatio":1.136544779456076,"shares":92963368,"dividePrice":0,"high":41.135,"amplitude":0.031752,"preClose":38.58,"low":39.91,"week52Low":16.5,"pbRate":"40.31","psRate":"68.72","week52High":48.45,"institutionHeld":0,"latestPrice":40.4987,"eps":-0.735552,"divideRate":0,"volume":11693,"delay":0,"ttmEps":-0.735552,"open":40.98,"prevYearClose":17.25,"prevWeekClose":42.47,"prevMonthClose":42.47,"prevQuarterClose":39.375,"fiveDayClose":41.1327,"twentyDayClose":42.81,"sixtyDayClose":29.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-20","symbol":"AAPG","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"date":"2025-03-27","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"盤前","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1743652800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AAPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AAPG","date":"2025-09-05","current":-22.946281,"percent":0.993421,"low":-76.454813,"twenty":-59.664109,"median":-36.382297,"eighty":-31.979778,"high":-21.702816,"avg":-42.586735,"sd":14.167338,"marketCap":3724203040.4},"quantilePoints":[{"date":"2025-01-31","current":-29.751262,"twenty":-29.75286,"median":-29.751983,"eighty":-29.751262,"marketCap":1478269659.08},{"date":"2025-02-07","current":-32.664532,"twenty":-32.365221,"median":-31.242401,"eighty":-29.752127,"marketCap":1614694688.16},{"date":"2025-02-14","current":-31.1828,"twenty":-32.258438,"median":-31.212601,"eighty":-29.752938,"marketCap":1540476496.81},{"date":"2025-02-21","current":-36.382297,"twenty":-32.721933,"median":-31.802125,"eighty":-29.819279,"marketCap":1806628873.73},{"date":"2025-02-28","current":-33.43308,"twenty":-34.468465,"median":-32.375664,"eighty":-30.230932,"marketCap":1654638501.56},{"date":"2025-03-07","current":-34.452224,"twenty":-34.328072,"median":-32.712367,"eighty":-30.892818,"marketCap":1712841480.27},{"date":"2025-03-14","current":-33.065652,"twenty":-34.096417,"median":-32.760201,"eighty":-31.20664,"marketCap":1644428002.08},{"date":"2025-03-21","current":-32.72391,"twenty":-34.124503,"median":-32.947597,"eighty":-31.448698,"marketCap":1626713850.02},{"date":"2025-03-28","current":-33.955809,"twenty":-34.124503,"median":-33.010704,"eighty":-31.793328,"marketCap":1894714451.86},{"date":"2025-04-04","current":-35.921968,"twenty":-34.855052,"median":-33.21342,"eighty":-31.979778,"marketCap":2000185586.04},{"date":"2025-04-11","current":-29.511221,"twenty":-34.370118,"median":-33.010704,"eighty":-30.892818,"marketCap":1635879540.94},{"date":"2025-04-17","current":-29.520055,"twenty":-34.225935,"median":-32.760201,"eighty":-30.07059,"marketCap":1639709582.7},{"date":"2025-04-25","current":-41.553435,"twenty":-35.045268,"median":-32.920123,"eighty":-30.119556,"marketCap":2311372741.24},{"date":"2025-05-02","current":-38.492689,"twenty":-35.554336,"median":-33.187028,"eighty":-30.682879,"marketCap":2146245101.28},{"date":"2025-05-09","current":-37.35919,"twenty":-36.170996,"median":-33.361942,"eighty":-30.776099,"marketCap":2093177176.92},{"date":"2025-05-16","current":-35.007117,"twenty":-35.955639,"median":-33.43308,"eighty":-31.102567,"marketCap":1969122395.28},{"date":"2025-05-23","current":-39.338512,"twenty":-36.352488,"median":-33.608398,"eighty":-31.19472,"marketCap":2213435510.22},{"date":"2025-05-30","current":-38.856398,"twenty":-37.35919,"median":-33.992043,"eighty":-31.242401,"marketCap":2192363417.29},{"date":"2025-06-06","current":-42.814884,"twenty":-37.865895,"median":-34.141844,"eighty":-31.758144,"marketCap":2419987007.19},{"date":"2025-06-13","current":-48.171029,"twenty":-38.492689,"median":-34.477812,"eighty":-31.846105,"marketCap":2722575737.57},{"date":"2025-06-20","current":-55.929302,"twenty":-38.862859,"median":-34.635358,"eighty":-32.113451,"marketCap":3154688383.5},{"date":"2025-06-27","current":-59.787237,"twenty":-39.399619,"median":-35.123604,"eighty":-32.336589,"marketCap":3381751544.24},{"date":"2025-07-03","current":-64.068526,"twenty":-41.436089,"median":-35.258863,"eighty":-32.429915,"marketCap":3624015684.35},{"date":"2025-07-11","current":-59.084566,"twenty":-43.897892,"median":-35.501693,"eighty":-32.48435,"marketCap":3338745741.38},{"date":"2025-07-18","current":-61.880278,"twenty":-48.308604,"median":-35.791073,"eighty":-32.545465,"marketCap":3494679880.36},{"date":"2025-07-25","current":-58.315576,"twenty":-54.849764,"median":-35.921968,"eighty":-32.616809,"marketCap":3304687864.64},{"date":"2025-08-01","current":-60.559654,"twenty":-57.422661,"median":-36.233253,"eighty":-32.655768,"marketCap":3410643633.03},{"date":"2025-08-08","current":-69.260076,"twenty":-59.023969,"median":-36.597865,"eighty":-32.679287,"marketCap":3910472388.03},{"date":"2025-08-15","current":-72.346957,"twenty":-59.602544,"median":-37.391167,"eighty":-32.709995,"marketCap":4086922647.44},{"date":"2025-08-22","current":-26.724459,"twenty":-60.097702,"median":-37.493155,"eighty":-32.679287,"marketCap":4314209810.62},{"date":"2025-08-29","current":-24.396919,"twenty":-59.865528,"median":-36.699167,"eighty":-32.48435,"marketCap":3966417985.85},{"date":"2025-09-05","current":-22.946281,"twenty":-59.664109,"median":-36.382297,"eighty":-31.979778,"marketCap":3724203040.4}],"updateTime":1757185942609},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAPG\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560978538","title":"亞盛醫藥-B(06855)：利生妥®一線治療中高危MDS患者的全球註冊III期臨牀研究獲美國FDA和歐洲EMA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2560978538","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560978538?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 07:34","pubTimestamp":1755473685,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B 发布公告，公司自主研发的Bcl-2选择性抑制剂利沙托克拉联合阿扎胞苷一线治疗新诊断的中高危骨髓增生异常综合症患者的全球注册III期临床研究获美国食品药品监督管理局和欧洲药品管理局同意开展。截止本公告日期，利生妥也是国际上唯一正推进中高危MDS注册III期临床的Bcl-2抑制剂。利生妥为中国首个获批上市的国产原创Bcl-2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4081","III","BK1574","06855","BK1161","EMA","BK4134","AAPG","BK4139"],"gpt_icon":0},{"id":"2559834599","title":"亞盛醫藥-B08月13日獲主力加倉1320.6萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559834599","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559834599?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 16:15","pubTimestamp":1755072937,"startTime":"0","endTime":"0","summary":"08月13日, 亚盛医药-B股价涨3.45%，报收81.00元，成交金额2.4亿元，换手率0.81%，振幅4.28%，量比0.60。亚盛医药-B今日主力资金净流入1320.6万元，上一交易日主力净流入1520.2万元。该股近5个交易日下跌3.11%，主力资金累计净流出1928.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5246.8万元，其中净流出天数为12日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813170129a485ff36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813170129a485ff36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2558691272","title":"亞盛醫藥8月11日成交額為9.30萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558691272","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558691272?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 09:15","pubTimestamp":1754961314,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，亚盛医药成交额为9.30万美元，成交额较昨日减少64.22%，当日成交量为2326.00股。亚盛医药于2025年8月11日跌4.55%，报40.04美元，该股过去5个交易日涨6.49%，年初至今涨132.12%，过去60日涨71.11%。公司专注于开发抑制蛋白质相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091521a482e0f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091521a482e0f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2557957884","title":"亞盛醫藥-B：董事會會議通告","url":"https://stock-news.laohu8.com/highlight/detail?id=2557957884","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557957884?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 21:41","pubTimestamp":1754660495,"startTime":"0","endTime":"0","summary":"亚盛医药集团宣布，将于2025年8月20日（星期三）召开董事会会议，主要议程为审议及批准集团截至2025年6月30日止六个月之未经审核中期业绩，并讨论相关业绩发布事宜。本次会议由董事会主席兼执行董事杨大俊博士主持，董事会成员包括非执行董事王少萌博士、吕大忠博士，以及独立非执行董事叶长青先生、任为先生、David Sidransky博士、Marina S. Bozilenko女士、Debra Yu博士及Marc E. Lippman, MD。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220437a6db2d80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220437a6db2d80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574","AAPG"],"gpt_icon":0},{"id":"2558043925","title":"小摩：升亞盛醫藥目標價至93港元 評級“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2558043925","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558043925?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 15:33","pubTimestamp":1754638380,"startTime":"0","endTime":"0","summary":"　　摩根大通发布研报称，亚盛医药股价年内累涨约83%，与恒生医疗保健指数的强劲表现同步。该行在最近举行的中美生物技术论坛与管理层讨论后，并考虑公司产品管线的最新进展，小摩更新了模型。小摩纳入对产品更乐观的销售预估，将亚盛医药目标价由原先52港元大幅上调79%至93港元；维持增持评级。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-08-08/doc-infkhfmz5145209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AAPG"],"gpt_icon":0},{"id":"2557488255","title":"小摩：升亞盛醫藥(06855.HK)目標價至93港元 評級“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2557488255","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557488255?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 14:13","pubTimestamp":1754633621,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2746668974.SGD","IE0034235188.USD","LU2456880835.USD","IE00BZ1G4Q59.USD","LU2462157665.USD","LU0976567544.SGD","LU0787776722.HKD","LU1894683348.USD","BK4504","IE00BLSP4452.SGD","LU1720051108.HKD","IE000M9KFDE8.USD","LU0211331839.USD","LU2756315664.SGD","06855","LU0820561909.HKD","LU0417517546.SGD","LU1668664300.SGD","SG9999002232.USD","LU0971096721.USD","AAPG","LU0234572021.USD","IE00BLSP4239.USD","LU2023250843.SGD","LU0345769631.USD","159506","LU2237443382.USD","LU0048584097.USD","LU1974910355.USD","SG9999002224.SGD","BK4581","LU1670627923.USD","LU1244550577.SGD","LU1551013425.SGD","LU1032466523.USD","LU1670628061.USD","LU0215105999.USD","LU1551013342.USD","LU2237443895.HKD","IE00B3S45H60.SGD","LU1917777945.USD","BK1161","LU0203347892.USD","LU0251132253.USD","LU0211326839.USD","LU0320765489.SGD","LU1914381329.SGD","LU2505996681.GBP","LU2756315318.SGD","LU0496365809.HKD"],"gpt_icon":0},{"id":"2557184755","title":"亞盛醫藥8月7日成交額為13.12萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557184755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557184755?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 09:15","pubTimestamp":1754615715,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，亚盛医药成交额为13.12万美元，成交额较昨日减少80.34%，当日成交量为3054.00股。亚盛医药于2025年8月7日涨0.3%，报42.81美元，该股过去5个交易日涨15.7%，年初至今涨148.17%，过去60日涨76.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|13.12万|-80.34%|3054.00|#|2025-08-06|66.76万|-13.27%|1.56万|#|2025-08-05|76.97万|610.80%|1.82万|#|2025-08-04|10.83万|-69.86%|2890.00|#|2025-08-01|35.92万|236.22%|9770.00|亚盛医药集团是一家临床阶段的生物技术公司，从事癌症、乙型肝炎病毒和某些年龄相关疾病的新型小规模疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808091527a47bfa2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808091527a47bfa2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2557095153","title":"亞盛醫藥上漲2.38%，報43.0美元/股，總市值39.97億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557095153","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557095153?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 01:04","pubTimestamp":1754499858,"startTime":"0","endTime":"0","summary":"8月7日，亚盛医药盘中上涨2.38%，截至01:04，报43.0美元/股，成交57.98万美元，总市值39.97亿美元。财务数据显示，截至2024年12月31日，亚盛医药收入总额9.81亿人民币，同比增长341.77%；归母净利润-4.05亿人民币，同比增长56.2%。目前公司正在中国、美国、澳大利亚及欧洲开展40多项临床试验。截至目前,公司共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定,2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/07010452260174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2557358048","title":"亞盛醫藥8月4日成交額為10.83萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557358048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557358048?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 09:15","pubTimestamp":1754356515,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，亚盛医药成交额为10.83万美元，成交额较昨日减少69.86%，当日成交量为2890.00股。亚盛医药于2025年8月4日涨1.08%，报37.6美元，该股过去5个交易日跌4.25%，年初至今涨117.97%，过去60日涨55.56%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|10.83万|-69.86%|2890.00|#|2025-08-01|35.92万|236.22%|9770.00|#|2025-07-31|10.68万|-63.12%|2893.00|#|2025-07-30|28.97万|49.26%|7639.00|#|2025-07-29|19.41万|-50.35%|4877.00|亚盛医药集团是一家临床阶段的生物技术公司，从事癌症、乙型肝炎病毒和某些年龄相关疾病的新型小规模疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091530a6d35278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091530a6d35278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2556844453","title":"亞盛醫藥8月1日成交額為35.92萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556844453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556844453?lang=zh_tw&edition=fundamental","pubTime":"2025-08-02 09:15","pubTimestamp":1754097315,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，亚盛医药成交额为35.92万美元，成交额较昨日增加236.22%，当日成交量为9770.00股。亚盛医药于2025年8月1日涨0.54%，报37.2美元，该股过去5个交易日跌1.59%，年初至今涨115.65%，过去60日涨44.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|35.92万|236.22%|9770.00|#|2025-07-31|10.68万|-63.12%|2893.00|#|2025-07-30|28.97万|49.26%|7639.00|#|2025-07-29|19.41万|-50.35%|4877.00|#|2025-07-28|39.09万|211.84%|9883.00|亚盛医药集团是一家临床阶段的生物技术公司，从事癌症、乙型肝炎病毒和某些年龄相关疾病的新型小规模疗法的开发和销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091529a470959a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091529a470959a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2555107634","title":"亞盛醫藥7月30日成交額為28.97萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555107634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555107634?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 09:15","pubTimestamp":1753924515,"startTime":"0","endTime":"0","summary":"美东时间2025年7月30日，亚盛医药成交额为28.97万美元，成交额较昨日增加49.26%，当日成交量为7639.00股。亚盛医药于2025年7月30日跌6.44%，报37.5美元，该股过去5个交易日跌2.11%，年初至今涨117.39%，过去60日涨47.17%。公司专注于开发抑制蛋白质相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091523a6ca7dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091523a6ca7dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2555069153","title":"亞盛醫藥上漲2.29%，報40.168美元/股，總市值37.34億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555069153","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555069153?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 03:59","pubTimestamp":1753819150,"startTime":"0","endTime":"0","summary":"7月30日，亚盛医药盘中上涨2.29%，截至03:59，报40.168美元/股，成交18.09万美元，总市值37.34亿美元。财务数据显示，截至2024年12月31日，亚盛医药收入总额9.81亿人民币，同比增长341.77%；归母净利润-4.05亿人民币，同比增长56.2%。目前公司正在中国、美国、澳大利亚及欧洲开展40多项临床试验。截至目前,公司共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定,2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073004044194c2374a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073004044194c2374a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","ASPHF","BK4139"],"gpt_icon":0},{"id":"2555039721","title":"國內首款Bcl-2抑制劑利生妥®在京東健康全網首發 助力血液腫瘤精準治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2555039721","media":"砍柴网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555039721?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 00:00","pubTimestamp":1753718400,"startTime":"0","endTime":"0","summary":"近日，亚盛医药自主研发的新型口服Bcl-2选择性抑制剂——利生妥在京东健康全网独家首发。通过选择性抑制Bcl-2蛋白，恢复肿瘤细胞的正常凋亡过程，可达到治疗肿瘤的目的。在此之前，中国尚未有Bcl-2抑制剂获批用于CLL/SLL的治疗。今年7月，利生妥正式在国内上市后，选择在京东健康线上首发，正是看重线上渠道能实现药品更广泛可及的优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072916471394c129b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072916471394c129b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","PPI","06618","86618","BK4139","BK4570","06855"],"gpt_icon":0},{"id":"2554708953","title":"特朗普再喊話：美聯儲必須降息！美股小幅上漲，金價急跌！這隻中概股大漲超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554708953","media":"每经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554708953?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 23:40","pubTimestamp":1753717220,"startTime":"0","endTime":"0","summary":"央视新闻消息，当地时间7月28日，美国总统特朗普表示，美联储必须降息。美联储主席鲍威尔任期至2026年5月结束。当地时间27日，特朗普与冯德莱恩达成一致，双方同意实行统一的15%关税税率。特朗普表示，欧盟将比此前增加对美国投资6000亿美元，欧盟将购买美国军事装备，并将购买价值7500亿美元的美国能源产品冯德莱恩表示，协议中对汽车行业的关税统一定为15%。冯德莱恩称，这些与美国的贸易协议将为市场带来稳定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823405697237ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"6982a326db9f98c303f24b3ceddda199","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823405697237ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","ELPW","BK1574","06855","BK1161","TSLA","ZLAB","AAPG"],"gpt_icon":0},{"id":"2554877761","title":"美股高開 中概股多數上揚 阿里巴巴漲超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554877761","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554877761?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 21:33","pubTimestamp":1753709583,"startTime":"0","endTime":"0","summary":"格隆汇7月28日｜美股三大指数小幅高开，道指涨0.03%，纳指涨0.31%，标普500指数涨0.15%。 多数中概股盘初上扬，小马智行涨超7%，禾赛、亚盛医药涨超5%，腾讯音乐、阿里巴巴涨超2%。 激光雷达公司AEye涨超20%，上个交易日收涨超50%。 以太坊概念股走强，Gamesquare Holdings涨5.3%，BTCS涨10.1%，Bit Digital涨3.5%。 能源板块上涨，Cheniere涨3.9%，Venture Global涨6.8%，NextDecade涨2.0%，欧盟同意购买价值7500亿美元的美国能源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821351494bf6ff1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d30d6729b2b220e45cad4800efb5d10d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821351494bf6ff1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","AAPG","06855"],"gpt_icon":0},{"id":"2554741740","title":"亞盛醫藥完成配售2200萬股 淨籌14.925億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554741740","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554741740?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 09:28","pubTimestamp":1753666083,"startTime":"0","endTime":"0","summary":"2025年7月25日，亚盛医药-B（06855）完成先旧后新配售2200万股股份，配售价每股68.60港元，净筹约14.925亿港元。所得款项将用于推进公司商业化工作、全球临床开发及加强全球运营基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809291297221ecf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809291297221ecf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2554741969","title":"首款國產Bcl-2抑制劑“首方”快速落地，釋放的4個信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2554741969","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554741969?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 09:17","pubTimestamp":1753665430,"startTime":"0","endTime":"0","summary":"Bcl-2抑制剂的价值，也已经被艾伯维充分验证。根据亚盛医药公布的2期临床数据，在Bcl-2抑制剂CLL/SLL领域，利生妥与阿卡替尼联用治疗初治CLL/SLL患者的ORR达100%，在R/R CLL/SLL中的ORR仍达98%。因为毒性问题，维奈克拉并不能解锁Bcl-2抑制剂所有潜在适应症。在攻克Bcl-2抑制剂之前，公司的首发管线耐立克就是在“Hard”赛道上实现突围的。在利生妥获批之前，全球历经40年也仅有维奈克拉一款Bcl-2抑制剂获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728092025a6c4d418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728092025a6c4d418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","AAPG","BK1574"],"gpt_icon":0},{"id":"2554156743","title":"振東製藥股價異動 周內上漲超40%；康方生物明星藥物衝刺非小細胞肺癌第三項適應證 | 掘金創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2554156743","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554156743?lang=zh_tw&edition=fundamental","pubTime":"2025-07-27 22:09","pubTimestamp":1753625373,"startTime":"0","endTime":"0","summary":"最受关注研发进展：康方生物明星药物冲刺非小细胞肺癌第三项适应证事件：7月25日，国家药品监督管理局药品审评中心官网显示，康方生物的依沃西单抗新适应证上市申请已获受理。今年4月，康方生物披露过依沃西单抗这一适应证的临床研究进展。文章来源：每日经济新闻振东制药股价异动，周内上涨超40%；康方生物明星药物冲刺非小细胞肺癌第三项适应证 | 掘金创新药","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250727221707a6c44f47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250727221707a6c44f47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDE","06855","LU1223082519.USD","LU1223082196.USD","AAPG","BK4017","LU1223083913.SGD"],"gpt_icon":0},{"id":"2554109767","title":"亞盛醫藥-B(06855.HK)完成先舊後新配售2200萬股股份 淨籌約14.925億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554109767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554109767?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 20:35","pubTimestamp":1753446958,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AAPG","BK1161","06855","BK1574","BK4139"],"gpt_icon":0},{"id":"2554734794","title":"亞盛醫藥7月24日成交額為41.72萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554734794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554734794?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 09:15","pubTimestamp":1753406116,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，亚盛医药成交额为41.72万美元，成交额较昨日增加98.93%，当日成交量为1.05万股。亚盛医药于2025年7月24日涨3.78%，报39.76美元，该股过去5个交易日涨0.35%，年初至今涨130.49%，过去60日涨57.22%。公司专注于开发抑制蛋白质相互作用以恢复细胞凋亡或程序性细胞死亡的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725091524a6c08583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725091524a6c08583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":177,"code":"91000000","status":"200"}]}}